NEW YORK, NY / ACCESSWIRE / January 27, 2017 / Pomerantz LLP is investigating claims on behalf of investors of Banc of California, Inc. (“Banc of California” or the “Company”) (NASDAQ: BANC). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

The investigation concerns whether Banc of California and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here to join a class action]

On October 18, 2016, Seeking Alpha published a report alleging that Banc of California had concealed numerous connections between the Company and Jason Galanis, an individual convicted of criminal securities fraud, including that: (i) Banc of California Chief Executive Officer (“CEO”) Jason Sugarman was the founder, CEO, and indirect owner of a company controlled by Galanis; and (ii) separately, Galanis controlled Banc of California’s founding shareholder. The Seeking
Alpha report also alleged that Banc of California had used an off-balance sheet entity to make loans to insiders. On this news, Banc of California stock fell $4.61, or 29.05%, to close at $11.26 on October 18, 2016.

On November 10, 2016, Banc of California disclosed that it was delaying the filing of its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2016 in order for its Special Committee to complete a review into certain purported improper relationships and related party transactions.

On January 23, 2017, Banc of California announced Sugarman’s resignation as CEO and that the U.S. Securities and Exchange Commission had opened an investigation into whether Banc of California had misled investors in its response to the October 2016 Seeking Alpha report. On this news, Banc of California stock has fallen as much as $1.75, or 10.84%, to a low of $14.40 on January 23, 2017.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

SOURCE: Pomerantz LLP

ReleaseID: 453697

NEW YORK, NY / ACCESSWIRE / January 27, 2017 / Pomerantz LLP is investigating claims on behalf of investors of Mallinckrodt plc (“Mallinckrodt” or the “Company”) (NYSE: MNK). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

The investigation concerns whether Mallinckrodt and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here to join a class action]

Since its August 2014 acquisition of Questcor Pharmaceuticals, Inc., Mallinckrodt’s drug portfolio has included HP Acthar Gel (“Acthar”), an injectable adrenocorticotropic hormone (“ACTH”) drug.

On November 16, 2016, Citron Research published a report (the “Citron Report”) accusing Mallinckrodt and its Chief Executive Officer, Mark Trudeau, of downplaying the Company’s reliance on Medicare and Medicaid for Acthar revenue. According to the Citron Report, a review of information published by the Centers for Medicare and Medicaid Services indicated that Medicare and Medicaid payments collectively amounted to 61.32% of Mallinckrodt’s Acthar revenues in 2015. Following the Citron Report, Mallinckrodt’s share price fell $8.15, or 12.02%, to close at $59.65 on November 16, 2016.

On November 29, 2016, during a conference call, Trudeau advised investors “Acthar now represents a significantly greater proportion of our operating income than one-third.” On this news, Mallinckrodt’s share price fell $5.25, or 9.1%, to close at $52.42 on November 29, 2016.

On January 18, 2017, the Federal Trade Commission (“FTC”) announced that Mallinckrodt had agreed to pay $100 million in connection with a joint settlement with the FTC and several states concerning charges that the Company’s efforts to stifle competing ACTH drugs had violated U.S. antitrust laws. On news of the settlement, Mallinckrodt’s share price fell $2.89, or 5.85%, to close at $46.53 on January 18, 2017.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

SOURCE: Pomerantz LLP

ReleaseID: 453696

NEW YORK, NY / ACCESSWIRE / January 27, 2017 / Pomerantz LLP is investigating claims on behalf of investors of The Western Union Company (“Western Union” or the “Company”) (NYSE: WU). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

The investigation concerns whether Western Union and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here to join a class action]

On January 19, 2017, the U.S. Department of Justice and the Federal Trade Commission announced that Western Union had agreed to pay $586 million and admitted to “aiding and abetting wire fraud” by allowing scammers to process transactions even when the Company realized that its agents were disguising transactions to avoid detection.

On this news, Western Union stock fell 3.30%, or $0.72, to close at $21.13 on January 19, 2017.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

SOURCE: Pomerantz LLP

ReleaseID: 453694

NEW YORK, NY / ACCESSWIRE / January 27, 2017 / Pomerantz LLP is investigating claims on behalf of investors of State Street Corporation (“State Street” or the “Company”) (NYSE: STT). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

The investigation concerns whether State Street and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here to join a class action]

On January 18, 2017, the U.S. Department of Justice announced that State Street had entered into a deferred prosecution agreement and agreed to pay a $32.3 million criminal penalty to resolve charges that the Company had engaged in a scheme to defraud a number of the bank’s clients by secretly applying commissions to billions of dollars of securities trades. State Street also agreed to offer an equal amount as a civil penalty to the U.S. Securities and Exchange Commission, for an aggregate settlement of more than $64 million. State Street admitted to the allegations and agreed to a deferred prosecution agreement that requires it to employ an independent corporate compliance monitor for three years.

On this news, State Street stock fell $0.05, or 0.06%, to close at $80.15 on January 18, 2017.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

SOURCE: Pomerantz LLP

ReleaseID: 453693

LOS ANGELES, CA / ACCESSWIRE / January 27, 2017 / Lundin Law PC, a shareholder rights firm announces a class action lawsuit against Fenix Parts, Inc. (“Fenix” or the “Company”) (Nasdaq: FENX). Investors, who purchased or otherwise acquired shares between May 15, 2015 and October 12, 2016 inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the
March 13, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

According to the Complaint, during the Class Period, Fenix made false and/or misleading statements and/or failed to disclose: that its inventory valuation tools were insufficient; that its tools to measure goodwill impairment were insufficient; that it had engaged in activity that would cause a SEC investigation; and that as a result of the above, Fenix’s statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

When this information was revealed to the public, the value of Fenix stock dropped, causing investors harm.

Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com

SOURCE: Lundin Law PC

ReleaseID: 453695

NEW YORK, NY / ACCESSWIRE / January 27, 2017 / Pomerantz LLP is investigating claims on behalf of investors of PixarBio Corporation (“PixarBio” or the “Company”) (OTC PINK: PXRB). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

The investigation concerns whether PixarBio and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here to join a class action]

On January 3, 2017, PixarBio’s Chief Executive Officer, Frank Reynolds, announced a purported effort by PixarBio to acquire InVivo Therapeutics Holdings Corp. (“InVivo”). InVivo subsequently stated that it had never engaged in any discussions regarding a possible deal and dismissed the purported offer as “not credible.”

On January 23, 2017, the U.S. Securities and Exchange Commission halted trading in the securities of PixarBio, citing concerns about possible “manipulative or deceptive activities” in the market for the Company’s stock. The SEC stated, in part, that “the market for the security appears to reflect manipulative or deceptive activities and because of questions regarding the accuracy of assertions by PixarBio in press releases and its Form S-1 concerning, among other things: (1) the company’s business combinations and current shareholders; (2) the identity and qualifications of key shareholders and employees; and (3) the company’s current and prospective development efforts.”

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

SOURCE: Pomerantz LLP

ReleaseID: 453691

NEW YORK, NY / ACCESSWIRE / January 27, 2017 / Pomerantz LLP is investigating claims on behalf of investors of NCI, Inc. (“NCI” or the “Company”) (NASDAQ: NCIT). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

The investigation concerns whether NCI and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here to join a class action]

On January 23, 2017, NCI announced that based on the preliminary findings of an internal investigation, NCI’s controller embezzled at least $18 million from the Company over the past six years. NCI’s findings thus far indicate that the embezzled funds were reflected as expenses in the Company’s financial statements, and concluded that the unaudited interim financial statements for the nine-month period ending September 30, 2016 contain material errors related to the theft, and, therefore, should not be relied upon by investors. NCI stated that it will provide amended financial results for that nine-month period as part of the completion of its financial reporting process for the fiscal year 2016.

On this news, NCI stock has fallen as much as $1.60, or 11.47%, to a low of $12.35 during intraday trading on January 23, 2017.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

SOURCE: Pomerantz LLP

ReleaseID: 453692

IRVINE, CA / ACCESSWIRE / January 27, 2017 / Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against General Cable Corporation (“General Cable” or the “Company”) (NYSE: BGC). Investors, who purchased or otherwise acquired shares between February 23, 2012 and February 10, 2016 inclusive (the “Class Period”), are encouraged to contact the Firm prior to the March 6, 2017 lead plaintiff motion deadline.

If you purchased shares of General Cable during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

On February 10, 2016, General Cable stated that it could have incurred more than $33 million in profits through transactions violating the FCPA, an amount that would have to be disgorged, with interest. When this information was released to the investing public, the value of General Cable fell $3.05 per share or over 31.6% from its previous closing price to close at $6.60 per share on February 11, 2016.

The U.S. Department of Justice then issued the following statement: “[b]etween 2002 and 2013, General Cable subsidiaries paid approximately $13 million to third-party agents and distributors, a portion of which was used to make unlawful payments to obtain business, ultimately netting the company approximately $51 million in profits.” Upon the release of this information to the public, the value of General Cable fell sharply, causing investors serious harm.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

If you wish to learn more about this lawsuit, at no charge, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 453690